Study groupHIP |
Control group40–49 |
Study group12 |
Control group1963 |
RR (95% CI)13,740 |
Study group13,740 |
Control group19 |
RR (95% CI)Breast cancer mortality at mid-range follow-up (6 to 8 years)20 |
0.95 (0.51–1.78) |
Breast cancer mortality at 14-year follow-up64 |
Breast cancer mortality at 14-year follow-up82 |
Breast cancer mortality at 14-year follow-up0.78 (0.56–1.08) |
Study groupMalmö |
Control group45–54 |
Study group18–24 |
Control group1976 |
RR (95% CI)13,568 |
Study group12,279 |
Control groupN/A |
RR (95% CI)Breast cancer mortality at mid-range follow-up (6 to 8 years)N/A |
N/A |
Breast cancer mortality at 14-year follow-up53 |
Breast cancer mortality at 14-year follow-up66 |
Breast cancer mortality at 14-year follow-up0.73 (0.51–1.04) |
Study groupÖstergötland (E-County) |
Control group40–49 |
Study group24 |
Control group1977 |
RR (95% CI)10,285 |
Study group10,459 |
Control group15 |
RR (95% CI)Breast cancer mortality at mid-range follow-up (6 to 8 years)15 |
1.03 (0.50–2.11) |
Breast cancer mortality at 14-year follow-up31 |
Breast cancer mortality at 14-year follow-up30 |
Breast cancer mortality at 14-year follow-up1.05 (0.64–1.73) |
Study groupKopparberg (W-County) |
Control group40–49 |
Study group24 |
Control group1977 |
RR (95% CI)9,582 |
Study group5,031 |
Control group13 |
RR (95% CI)Breast cancer mortality at mid-range follow-up (6 to 8 years)9 |
0.76 (0.32–1.77) |
Breast cancer mortality at 14-year follow-up22 |
Breast cancer mortality at 14-year follow-up16 |
Breast cancer mortality at 14-year follow-up0.72 (0.38–1.37) |
Study groupCNBSS-1 |
Control group40–49 |
Study group12 |
Control group1980 |
RR (95% CI)25,214 |
Study group25,216 |
Control group38 |
RR (95% CI)Breast cancer mortality at mid-range follow-up (6 to 8 years)28 |
1.36 (0.84–2.21) |
Breast cancer mortality at 14-year follow-up105 |
Breast cancer mortality at 14-year follow-up108 |
Breast cancer mortality at 14-year follow-up0.97 (0.74–1.27) |
Study groupStockholm |
Control group40–49 |
Study group28 |
Control group1981 |
RR (95% CI)14,303 |
Study group8,021 |
Control group16 |
RR (95% CI)Breast cancer mortality at mid-range follow-up (6 to 8 years)8 |
1.09 (0.40–3.00) |
Breast cancer mortality at 14-year follow-up34 |
Breast cancer mortality at 14-year follow-up13 |
Breast cancer mortality at 14-year follow-up1.47 (0.77–2.78) |
Study groupGöteborg |
Control group39–49 |
Study group18 |
Control group1982 |
RR (95% CI)11,724 |
Study group14,217 |
Control group16 |
RR (95% CI)Breast cancer mortality at mid-range follow-up (6 to 8 years)33 |
0.59 (0.33–1.06) |
Breast cancer mortality at 14-year follow-up34 |
Breast cancer mortality at 14-year follow-up59 |
Breast cancer mortality at 14-year follow-up0.70 (0.46–1.06) |
Study groupUK AGE |
Control group39–41 |
Study group12 |
Control group1991 |
RR (95% CI)53,884 |
Study group106,956 |
Control group26 |
RR (95% CI)Breast cancer mortality at mid-range follow-up (6 to 8 years)65 |
0.79 (0.48–1.27) |
Breast cancer mortality at 14-year follow-up105 |
Breast cancer mortality at 14-year follow-up251 |
Breast cancer mortality at 14-year follow-up0.83 (0.66–1.04) |